Lipid-Drug Conjugates

PART A: Innovations in Lipid-Drug Conjugates
1. Lipid-drug conjugates: application of lipid in drug delivery
2. Lipid-drug conjugates: Conjugation methods and therapeutic benefits
3. Route of administration and cellular interaction of lipid-drug conjugates
4. Lipid -drug conjugates for enhanced drug delivery and targeting
5. Antibody conjugated lipid nanoparticles as a targeted drug delivery systems for hydrophobic drugs
6. Pharmacokinetics of lipid-drug conjugates
7. Production and characterization of various delivery carriers for lipid-drug conjugates

PART B: Applications of lipid-drug conjugates
8. Lipid-drug conjugates for cancer chemotherapy
9. Lipid-drug conjugates for enhanced antiretroviral efficacy
10. Nano lipid-drug conjugates for the treatment of Alzheimer disease
11. Lipid-drug conjugates for the treatment of glioblastomas
12. Antibody-drug conjugates as cancer therapeutics
13. Antibacterial drug conjugates for bacterial diseases
14. Lipid-drug conjugates: Future perspectives, Industry trends and global forecast

Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.

• Farmacologia
• Tecnologia farmacêutica

; Amyloid-?; Anti-HIV; Antibody-conjugated nanoparticles; Antibody-drug conjugates; Antiretrovirals; Bacteria; Bioactives; Bioavailability; Blood-brain barrier; Bonds; Cancer chemotherapy; Cancer theranostics; Cell signaling; Conjugation; Conjugation chemistry; Conjugations; Delivery carriers; Drug; Drug delivery; Drug delivery system; Drug delivery systems; Drug development; Drug efficacy; Glioblastoma; High pressure homogenization; Hydrophobic drugs; Infectious disease; Linker; Linkers; Lipid drug conjugates; Lipid drug conjugation; Lipid nanocarriers; Lipid nanoparticles; Lipid-drug conjugate; Lipid-drug conjugates; Lipid-drug conjugates (LDC); Lipid-drug conjugates (LDCs); Lipids; Lipid-drug conjugate; Lipid-drug conjugates; Liposome; Liposomes; Membrane permeation; Micelles; Multimodal treatment; Nanocarriers; Nanocomplexes; Nanoparticle; Nanoparticles; Nanotechnology; Neurodegeneration; Pharmacokinetics; Prodrug; Prodrugs; ROS; Solid lipid nanoparticles; Synergistic effect; Targeted delivery; Targeted drug delivery; Targeted therapy; Toxicity